Versant Venture Capital VI, L.P. 13D and 13G filings for Black Diamond Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-08 4:48 pm Unchanged | 2024-08-06 | 13D | Black Diamond Therapeutics, Inc. BDTX | Versant Venture Capital VI, L.P. | 4,328,883 7.700% | 0 (Unchanged) | Filing |
| 2023-11-09 5:24 pm Unchanged | 2023-08-11 | 13D | Black Diamond Therapeutics, Inc. BDTX | Versant Venture Capital VI, L.P. | 4,328,883 8.400% | 0 (Unchanged) | Filing |